🟢 Adaptive Biotechnologies is trading 4% up today amid biotech-sector strength

Adaptive Biotechnologies is trading at $28.77, up 4.01%, amid biotech-sector strength.

• Biotech ETF XBI is up 2.18% in the regular session; major indexes are nearly flat.
• Available reports point to sector strength, not a new company-specific announcement on October 28.
• Investors are looking ahead to the November 4 third-quarter report; coverage highlights clonoSEQ momentum and expectations around MRD revenue guidance, but does not establish them as the cause of this morning’s move.